Skip to main content Back to Top

SICP Educational Steering Committee: Therapeutics: Aspirin Use for Primary Prevention

Broadcast Date: September 30, 2022


Subscribe on iTune PodcastsListen on Google PlaySubscribe to Stitcher Podcasts Listen on Spotify Subscribe to TuneIn PodcastsSubscribe to iHeartRadio

This podcast will review the current guidelines and summarize recent literature evaluating the use of aspirin for primary prevention. Additionally, the speakers will discuss how to talk with patients about the use of aspirin in primary prevention and when to desprescribe vs. continue therapy.


Cindy KingCindy King, PharmD, BCACP, is an ambulatory care pharmacy specialist at MetroHealth System focused on chronic disease management in diabetes, hyperlipidemia, hypertension, COPD, asthma, and tobacco cessation. Additionally, at Metrohealth, she serves as the Director of the PGY1 and PGY2 Ambulatory Care Residency Programs and the lead for the Ohio Department of Medicaid CGM pilot. She is an associate professor of pharmacy practice at Northeast Ohio Medical University. Cindy currently serves on the ASHP SACP SAG on Clinical Pharmacy Advancement.

Alex HoffmanAlexander Hoffman, PharmD, MEd, BCPS, CDCES, is an Ambulatory Care Clinical Pharmacy Specialist with the Cleveland Clinic and an Associate Professor of Pharmacy Practice at Northeast Ohio Medical University. He completed his Doctor of Pharmacy degree at Ohio Northern University, his Masters of Education at Cleveland State University, and his PGY1 Pharmacy Residency at Kaiser Permanente Medical Plan of Ohio. His research interests include pharmacy interventions in primary care, medical education, mentoring, professional development, and graphic medicine.

Maria BowenMaria F. Bowen, PharmD, is a Medication Safety and Drug Information Specialist at University Hospitals Health System. She received her Doctorate of Pharmacy from Ohio Northern University Raabe College of Pharmacy. She completed a PGY1 Pharmacy Practice Residency at University Hospitals Portage Medical Center and a PGY2 Medication-Use Safety and Policy Residency at Children's Hospital Colorado.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.